Experience with sulphamethoxazole (SMZ)/trimethoprim (TMP) combination in purulent meningitis not responding to conventional microbial therapy
Abstract
Tell infants ranging in age from two days to nine months with purulent meningitis who were considered therapeutic failures after conventional microbial therapy (i.e. ampicillin, chloramphenicol, gentamicin, amikin, cloxacillin in any combination) were included in this study. A solution consisting of SMZ 80 mg/mL and TMP 16 mg/mL in propylene glycol (Bactrilll, Hoffman-La Roche A.G. Basle/Switzerland) was given intravenously to the patients. The daily dose was 10 mg/kg BW TMP/24 hours for the first three days followed by 6 mg/kg BW TMP/24 hours divided in two doses given intravenously every 12 hours.
Nine patients recovered, 7 of them rapidly within 10 - 21 days after SMZ/TMP administration and the other 2 patients within 27 and 33 days respectively. One infant improved but died afterwards of complicatIons not related to the treatment.
No hematological nor cutaneous and gastrointestinal side effects were observed. The liver and renal function test performed on 3 out of 10 cases on the first few days of the commencement of treatment and 3 weeks later, were all within normal limits.
Our experience with the use of parenteral SMZ/TMP in infants with bacterial meningitis not responding to conventional microbial therapy gave encouraging results.
References
2. AVERY, G.S. (ed): Evaluations on new drugs; Trimethoprim - Sulphamethoxazole. Drugs. 1 : 7 ( 1971).
3. BERGAN, T. and BRODWALL, E.K. : Human Pharmacolcinetics of a Sulpha methoxazole - Trimethoprim combination. Acta Med. Scand. 192 : 483 (1972).
4. CALONGHI, G.F. and LELASI, G. : In •travenous therapy with a combination of Sulphamethoxazole.Trimethoprim in Purulent Meningitis (translation). G. Mal Infect. Parassit. 24 : 9 (1972).
5. CHEMOTHERAPEUTIC ROUTES IN MENINGITIS (Editorial). Br. med. J. - : 977 ( 1976).
6. GOTOFF, S.P. and BEHRMAN, R.E. : Neonatal septicemia, J. Pediatr. 76: 142 (1970).
7. KIRWAN, W.O. : Cerebrospinal Fluid Co-tranoxazole Levels. J. Irish med. Ass. 67 : 76 (1974).
8. LINDBERG, J.: ROSENHALL, U.: NYLEN, O. and RINGER, A.: Longterm outcome of Hemophilus influenzae meningitis related to Antibiotic treatment. Pediatrics 60 : 1 (1977).
9. MC CRACK EN, G.H. Jr.: The rate of bacteriologic response to antimicrobial therapy in Neonatal Meningitis. Am. J. Dis. Ch1Id. 123 : 547 (1972).
10. MORIZARIA, R.N.; WALTON, I.G. and PICKERING, D. : Neonates Meningitis treated with Trimethoprim and Sulphamethoxazole. Br. med J. II : 512 ( 1969).
11. J. RILEY, H.D. Jr.: Neonatal Meningitis (Editorial). J. infect. Dis. 125: 420 (1972).
12. SABEL, K.G. and BRANDBERG, A. : Treatment of Meningitis and Septicemia in Infancy wi,th Sulphamethoxazole-Trimethoprim combination. Acta Pediatr. scand. 64 : 25 (1975).
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Accepted 2017-01-24
Published 1981-02-28